NBY News and Press, NovaBay Pharmaceuticals Inc. From 09/12/22

NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Virtual Investor Conference to be held on September 15 th . Individual investors, institutional ...

Calm Cool + Corrected Eczema + Dermatitis Clinical Repair Balm to be Featured on “Girls’ Night In with Courtney & Jane” on September 13 at 9 p.m. Eastern Time NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a company developing an...

NovaBay Pharma ( NYSE: NBY ) said on Friday it had entered into a securities purchase agreement with certain institutional investors for a private placement of 3,250 shares of a newly created Series C Non-Voting Convertible Preferred Stock at a price of $1,000 per share. T...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces it has entered into a Securities Purchase Agreement with certain institutional investors in connection with a private placement of 3,250 shares of a newly cre...

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2022 Earnings Conference Call August 11, 2022, 04:30 PM ET Company Participants Jody Cain - LHA Investor Relations Justin Hall - Chief Executive Officer and General Counsel Andy Jones - Chief Financial Officer Kim Sharts...

NovaBay press release ( NYSE: NBY ): Q2 GAAP EPS of -$0.04 in-line. Revenue of $3.04M (+42.7% Y/Y) misses by $0.47M . For further details see: NovaBay GAAP EPS of -$0.04 in-line, revenue of $3.04M misses by $0.47M

Product revenue increased by 43% year-over-year, fueled by a growing product portfolio in the eyecare and skincare markets Continued year-over-year growth in online Avenova ® Spray unit sales Launched seven new OTC Avenova and DERMAdoctor ® products...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2022 after market close on Thursday, August 11, 2022 and will hold an investment community conference call that day beginning at ...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces the launch of a new marketing campaign targeting the large and growing number of w...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due t...